 | • レポートコード：GIR201114654 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、神経リハビリ治療の世界市場を調査対象にし、神経リハビリ治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（脳障害、脊髄障害、末梢神経障害、その他）、用途別分析（総合病院、リハビリ専門病院、地域リハビリセンター）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：VISHEE、DIH、NCC、Beijing Bo'ai Hospital、Haobro Medical Device、Beijing Rehabilitation Hospital of Capital Medical University、Aoyang Health、Tongji Hospital、CHIEFTAIN、Sun Java、PKUCare Rehabilitation Hospital、Beijing United Family Rehabilitation Hospital、Beijing Puhua International Hospital、Xiangyu Medical ・企業別売上、市場シェア ・神経リハビリ治療の地域別市場分析 ・神経リハビリ治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・神経リハビリ治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・神経リハビリ治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・神経リハビリ治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・神経リハビリ治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・神経リハビリ治療の種類別市場規模2015-2020：脳障害、脊髄障害、末梢神経障害、その他 ・神経リハビリ治療の用途別市場規模2015-2020：総合病院、リハビリ専門病院、地域リハビリセンター ・神経リハビリ治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Neurorehabilitation Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neurorehabilitation Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neurorehabilitation Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neurorehabilitation Therapy market has been segmented into:
Brain Injury
Spinal Cord Injury
Peripheral Nerve Injury
Other
By Application, Neurorehabilitation Therapy has been segmented into:
General Hospital
Rehabilitation Specialist Hospital
Community Rehabilitation Center
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neurorehabilitation Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Neurorehabilitation Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neurorehabilitation Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Neurorehabilitation Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Neurorehabilitation Therapy Market Share Analysis
Neurorehabilitation Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neurorehabilitation Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neurorehabilitation Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Neurorehabilitation Therapy are:
VISHEE
DIH
NCC
Beijing Bo’ai Hospital
Haobro Medical Device
Beijing Rehabilitation Hospital of Capital Medical University
Aoyang Health
Tongji Hospital
CHIEFTAIN
Sun Java
PKUCare Rehabilitation Hospital
Beijing United Family Rehabilitation Hospital
Beijing Puhua International Hospital
Xiangyu Medical
Table of Contents
1 Neurorehabilitation Therapy Market Overview
1.1 Product Overview and Scope of Neurorehabilitation Therapy
1.2 Classification of Neurorehabilitation Therapy by Type
1.2.1 Global Neurorehabilitation Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Neurorehabilitation Therapy Revenue Market Share by Type in 2019
1.2.3 Brain Injury
1.2.4 Spinal Cord Injury
1.2.5 Peripheral Nerve Injury
1.2.6 Other
1.3 Global Neurorehabilitation Therapy Market by Application
1.3.1 Overview: Global Neurorehabilitation Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 General Hospital
1.3.3 Rehabilitation Specialist Hospital
1.3.4 Community Rehabilitation Center
1.4 Global Neurorehabilitation Therapy Market by Regions
1.4.1 Global Neurorehabilitation Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Neurorehabilitation Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Neurorehabilitation Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Neurorehabilitation Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neurorehabilitation Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Neurorehabilitation Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neurorehabilitation Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 VISHEE
2.1.1 VISHEE Details
2.1.2 VISHEE Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 VISHEE SWOT Analysis
2.1.4 VISHEE Product and Services
2.1.5 VISHEE Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 DIH
2.2.1 DIH Details
2.2.2 DIH Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DIH SWOT Analysis
2.2.4 DIH Product and Services
2.2.5 DIH Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 NCC
2.3.1 NCC Details
2.3.2 NCC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 NCC SWOT Analysis
2.3.4 NCC Product and Services
2.3.5 NCC Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Beijing Bo’ai Hospital
2.4.1 Beijing Bo’ai Hospital Details
2.4.2 Beijing Bo’ai Hospital Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Beijing Bo’ai Hospital SWOT Analysis
2.4.4 Beijing Bo’ai Hospital Product and Services
2.4.5 Beijing Bo’ai Hospital Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Haobro Medical Device
2.5.1 Haobro Medical Device Details
2.5.2 Haobro Medical Device Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Haobro Medical Device SWOT Analysis
2.5.4 Haobro Medical Device Product and Services
2.5.5 Haobro Medical Device Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Beijing Rehabilitation Hospital of Capital Medical University
2.6.1 Beijing Rehabilitation Hospital of Capital Medical University Details
2.6.2 Beijing Rehabilitation Hospital of Capital Medical University Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Beijing Rehabilitation Hospital of Capital Medical University SWOT Analysis
2.6.4 Beijing Rehabilitation Hospital of Capital Medical University Product and Services
2.6.5 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Aoyang Health
2.7.1 Aoyang Health Details
2.7.2 Aoyang Health Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Aoyang Health SWOT Analysis
2.7.4 Aoyang Health Product and Services
2.7.5 Aoyang Health Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Tongji Hospital
2.8.1 Tongji Hospital Details
2.8.2 Tongji Hospital Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Tongji Hospital SWOT Analysis
2.8.4 Tongji Hospital Product and Services
2.8.5 Tongji Hospital Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 CHIEFTAIN
2.9.1 CHIEFTAIN Details
2.9.2 CHIEFTAIN Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CHIEFTAIN SWOT Analysis
2.9.4 CHIEFTAIN Product and Services
2.9.5 CHIEFTAIN Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sun Java
2.10.1 Sun Java Details
2.10.2 Sun Java Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sun Java SWOT Analysis
2.10.4 Sun Java Product and Services
2.10.5 Sun Java Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 PKUCare Rehabilitation Hospital
2.11.1 PKUCare Rehabilitation Hospital Details
2.11.2 PKUCare Rehabilitation Hospital Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 PKUCare Rehabilitation Hospital SWOT Analysis
2.11.4 PKUCare Rehabilitation Hospital Product and Services
2.11.5 PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Beijing United Family Rehabilitation Hospital
2.12.1 Beijing United Family Rehabilitation Hospital Details
2.12.2 Beijing United Family Rehabilitation Hospital Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Beijing United Family Rehabilitation Hospital SWOT Analysis
2.12.4 Beijing United Family Rehabilitation Hospital Product and Services
2.12.5 Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Beijing Puhua International Hospital
2.13.1 Beijing Puhua International Hospital Details
2.13.2 Beijing Puhua International Hospital Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Beijing Puhua International Hospital SWOT Analysis
2.13.4 Beijing Puhua International Hospital Product and Services
2.13.5 Beijing Puhua International Hospital Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Xiangyu Medical
2.14.1 Xiangyu Medical Details
2.14.2 Xiangyu Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Xiangyu Medical SWOT Analysis
2.14.4 Xiangyu Medical Product and Services
2.14.5 Xiangyu Medical Neurorehabilitation Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Neurorehabilitation Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Neurorehabilitation Therapy Players Market Share
3.2.2 Top 10 Neurorehabilitation Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Neurorehabilitation Therapy Revenue and Market Share by Regions
4.2 North America Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
5 North America Neurorehabilitation Therapy Revenue by Countries
5.1 North America Neurorehabilitation Therapy Revenue by Countries (2015-2020)
5.2 USA Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
6 Europe Neurorehabilitation Therapy Revenue by Countries
6.1 Europe Neurorehabilitation Therapy Revenue by Countries (2015-2020)
6.2 Germany Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
6.4 France Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Neurorehabilitation Therapy Revenue by Countries
7.1 Asia-Pacific Neurorehabilitation Therapy Revenue by Countries (2015-2020)
7.2 China Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
7.5 India Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
8 South America Neurorehabilitation Therapy Revenue by Countries
8.1 South America Neurorehabilitation Therapy Revenue by Countries (2015-2020)
8.2 Brazil Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Neurorehabilitation Therapy by Countries
9.1 Middle East & Africa Neurorehabilitation Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Neurorehabilitation Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Neurorehabilitation Therapy Market Forecast by Type (2019-2024)
10.3 Brain Injury Revenue Growth Rate (2015-2025)
10.4 Spinal Cord Injury Revenue Growth Rate (2015-2025)
10.5 Peripheral Nerve Injury Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Neurorehabilitation Therapy Market Segment by Application
11.1 Global Neurorehabilitation Therapy Revenue Market Share by Application (2015-2020)
11.2 Neurorehabilitation Therapy Market Forecast by Application (2019-2024)
11.3 General Hospital Revenue Growth (2015-2020)
11.4 Rehabilitation Specialist Hospital Revenue Growth (2015-2020)
11.5 Community Rehabilitation Center Revenue Growth (2015-2020)
12 Global Neurorehabilitation Therapy Market Size Forecast (2021-2025)
12.1 Global Neurorehabilitation Therapy Market Size Forecast (2021-2025)
12.2 Global Neurorehabilitation Therapy Market Forecast by Regions (2021-2025)
12.3 North America Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
12.6 South America Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Neurorehabilitation Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neurorehabilitation Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neurorehabilitation Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Neurorehabilitation Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. VISHEE Corporate Information, Location and Competitors
Table 6. VISHEE Neurorehabilitation Therapy Major Business
Table 7. VISHEE Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 8. VISHEE SWOT Analysis
Table 9. VISHEE Neurorehabilitation Therapy Product and Solutions
Table 10. VISHEE Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. DIH Corporate Information, Location and Competitors
Table 12. DIH Neurorehabilitation Therapy Major Business
Table 13. DIH Neurorehabilitation Therapy Total Revenue (USD Million) (2018-2019)
Table 14. DIH SWOT Analysis
Table 15. DIH Neurorehabilitation Therapy Product and Solutions
Table 16. DIH Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. NCC Corporate Information, Location and Competitors
Table 18. NCC Neurorehabilitation Therapy Major Business
Table 19. NCC Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 20. NCC SWOT Analysis
Table 21. NCC Neurorehabilitation Therapy Product and Solutions
Table 22. NCC Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Beijing Bo'ai Hospital Corporate Information, Location and Competitors
Table 24. Beijing Bo'ai Hospital Neurorehabilitation Therapy Major Business
Table 25. Beijing Bo'ai Hospital Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 26. Beijing Bo'ai Hospital SWOT Analysis
Table 27. Beijing Bo'ai Hospital Neurorehabilitation Therapy Product and Solutions
Table 28. Beijing Bo'ai Hospital Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Haobro Medical Device Corporate Information, Location and Competitors
Table 30. Haobro Medical Device Neurorehabilitation Therapy Major Business
Table 31. Haobro Medical Device Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 32. Haobro Medical Device SWOT Analysis
Table 33. Haobro Medical Device Neurorehabilitation Therapy Product and Solutions
Table 34. Haobro Medical Device Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Beijing Rehabilitation Hospital of Capital Medical University Corporate Information, Location and Competitors
Table 36. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Major Business
Table 37. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 38. Beijing Rehabilitation Hospital of Capital Medical University SWOT Analysis
Table 39. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Product and Solutions
Table 40. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Aoyang Health Corporate Information, Location and Competitors
Table 42. Aoyang Health Neurorehabilitation Therapy Major Business
Table 43. Aoyang Health Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 44. Aoyang Health SWOT Analysis
Table 45. Aoyang Health Neurorehabilitation Therapy Product and Solutions
Table 46. Aoyang Health Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Tongji Hospital Corporate Information, Location and Competitors
Table 48. Tongji Hospital Neurorehabilitation Therapy Major Business
Table 49. Tongji Hospital Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 50. Tongji Hospital SWOT Analysis
Table 51. Tongji Hospital Neurorehabilitation Therapy Product and Solutions
Table 52. Tongji Hospital Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. CHIEFTAIN Corporate Information, Location and Competitors
Table 54. CHIEFTAIN Neurorehabilitation Therapy Major Business
Table 55. CHIEFTAIN Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 56. CHIEFTAIN SWOT Analysis
Table 57. CHIEFTAIN Neurorehabilitation Therapy Product and Solutions
Table 58. CHIEFTAIN Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sun Java Corporate Information, Location and Competitors
Table 60. Sun Java Neurorehabilitation Therapy Major Business
Table 61. Sun Java Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 62. Sun Java SWOT Analysis
Table 63. Sun Java Neurorehabilitation Therapy Product and Solutions
Table 64. Sun Java Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. PKUCare Rehabilitation Hospital Corporate Information, Location and Competitors
Table 66. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Major Business
Table 67. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 68. PKUCare Rehabilitation Hospital SWOT Analysis
Table 69. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Product and Solutions
Table 70. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Beijing United Family Rehabilitation Hospital Corporate Information, Location and Competitors
Table 72. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Major Business
Table 73. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 74. Beijing United Family Rehabilitation Hospital SWOT Analysis
Table 75. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Product and Solutions
Table 76. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Beijing Puhua International Hospital Corporate Information, Location and Competitors
Table 78. Beijing Puhua International Hospital Neurorehabilitation Therapy Major Business
Table 79. Beijing Puhua International Hospital Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 80. Beijing Puhua International Hospital SWOT Analysis
Table 81. Beijing Puhua International Hospital Neurorehabilitation Therapy Product and Solutions
Table 82. Beijing Puhua International Hospital Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Xiangyu Medical Corporate Information, Location and Competitors
Table 84. Xiangyu Medical Neurorehabilitation Therapy Major Business
Table 85. Xiangyu Medical Neurorehabilitation Therapy Total Revenue (USD Million) (2017-2018)
Table 86. Xiangyu Medical SWOT Analysis
Table 87. Xiangyu Medical Neurorehabilitation Therapy Product and Solutions
Table 88. Xiangyu Medical Neurorehabilitation Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Neurorehabilitation Therapy Revenue (Million USD) by Players (2015-2020)
Table 90. Global Neurorehabilitation Therapy Revenue Share by Players (2015-2020)
Table 91. Global Neurorehabilitation Therapy Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Neurorehabilitation Therapy Revenue Market Share by Regions (2015-2020)
Table 93. North America Neurorehabilitation Therapy Revenue by Countries (2015-2020)
Table 94. North America Neurorehabilitation Therapy Revenue Market Share by Countries (2015-2020)
Table 95. Europe Neurorehabilitation Therapy Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Neurorehabilitation Therapy Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Neurorehabilitation Therapy Revenue by Countries (2015-2020)
Table 98. South America Neurorehabilitation Therapy Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Neurorehabilitation Therapy Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Neurorehabilitation Therapy Revenue Market Share by Countries (2015-2020)
Table 101. Global Neurorehabilitation Therapy Revenue (Million USD) by Type (2015-2020)
Table 102. Global Neurorehabilitation Therapy Revenue Share by Type (2015-2020)
Table 103. Global Neurorehabilitation Therapy Revenue Forecast by Type (2021-2025)
Table 104. Global Neurorehabilitation Therapy Revenue by Application (2015-2020)
Table 105. Global Neurorehabilitation Therapy Revenue Share by Application (2015-2020)
Table 106. Global Neurorehabilitation Therapy Revenue Forecast by Application (2021-2025)
Table 107. Global Neurorehabilitation Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Neurorehabilitation Therapy Picture
Figure 2. Global Neurorehabilitation Therapy Revenue Market Share by Type in 2019
Figure 3. Brain Injury Picture
Figure 4. Spinal Cord Injury Picture
Figure 5. Peripheral Nerve Injury Picture
Figure 6. Other Picture
Figure 7. Neurorehabilitation Therapy Revenue Market Share by Application in 2019
Figure 8. General Hospital Picture
Figure 9. Rehabilitation Specialist Hospital Picture
Figure 10. Community Rehabilitation Center Picture
Figure 11. Global Neurorehabilitation Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Neurorehabilitation Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Neurorehabilitation Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Neurorehabilitation Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Neurorehabilitation Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Neurorehabilitation Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Neurorehabilitation Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Neurorehabilitation Therapy Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Neurorehabilitation Therapy Revenue Market Share in 2019
Figure 20. Global Top 10 Players Neurorehabilitation Therapy Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Neurorehabilitation Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Neurorehabilitation Therapy Revenue Market Share by Regions (2015-2020)
Figure 24. Global Neurorehabilitation Therapy Revenue Market Share by Regions in 2018
Figure 25. North America Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Europe Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 28. South America Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 30. North America Neurorehabilitation Therapy Revenue Market Share by Countries (2015-2020)
Figure 31. North America Neurorehabilitation Therapy Revenue Market Share by Countries in 2019
Figure 32. USA Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Canada Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 35. Europe Neurorehabilitation Therapy Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Neurorehabilitation Therapy Revenue Market Share by Countries in 2019
Figure 37. Germany Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 38. UK Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 39. France Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Russia Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Italy Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Neurorehabilitation Therapy Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Neurorehabilitation Therapy Revenue Market Share by Countries in 2019
Figure 44. China Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Japan Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Korea Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 47. India Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 49. South America Neurorehabilitation Therapy Revenue Market Share by Countries (2015-2020)
Figure 50. South America Neurorehabilitation Therapy Revenue Market Share by Countries in 2019
Figure 51. Brazil Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Neurorehabilitation Therapy Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Neurorehabilitation Therapy Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 56. UAE Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Neurorehabilitation Therapy Revenue and Growth Rate (2015-2020)
Figure 59. Global Neurorehabilitation Therapy Revenue Share by Type (2015-2020)
Figure 60. Global Neurorehabilitation Therapy Revenue Share by Type in 2019
Figure 61. Global Neurorehabilitation Therapy Market Share Forecast by Type (2021-2025)
Figure 62. Global Brain Injury Revenue Growth Rate (2015-2020)
Figure 63. Global Spinal Cord Injury Revenue Growth Rate (2015-2020)
Figure 64. Global Peripheral Nerve Injury Revenue Growth Rate (2015-2020)
Figure 65. Global Other Revenue Growth Rate (2015-2020)
Figure 66. Global Neurorehabilitation Therapy Revenue Share by Application (2015-2020)
Figure 67. Global Neurorehabilitation Therapy Revenue Share by Application in 2019
Figure 68. Global Neurorehabilitation Therapy Market Share Forecast by Application (2021-2025)
Figure 69. Global General Hospital Revenue Growth Rate (2015-2020)
Figure 70. Global Rehabilitation Specialist Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Community Rehabilitation Center Revenue Growth Rate (2015-2020)
Figure 72. Global Neurorehabilitation Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Neurorehabilitation Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Neurorehabilitation Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
Figure 76. Europe Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
Figure 78. South America Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Neurorehabilitation Therapy Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
免疫細胞療法の世界市場 2020年 Market Overview The Immunocell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…- 遺伝子治療の世界市場 2020年 Market Overview The Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- コントラストセラピーユニットの世界市場 2020年 Market Overview The global Contrast Therapy Units market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Contrast Therapy Units…
- コラーゲン修復療法の世界市場 2020年 Market Overview The global Collagen Restoration Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Collagen Restora…
- 抗凝固療法デバイスの世界市場 2020年 Market Overview The global Anticoagulation Therapy Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anticoagulati…